Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis Jodar

Showing results (31-40 of 151) with videos related to

Pageof 16
Sort By:
Infectious Diseases and Therapy|December 23, 2025
How do Recent Population-Level RSVpreF Vaccine-Impact Results from the United Kingdom Relate to Previously Reported Vaccine Effectiveness Results?Negar Aliabadi, Qing Liu, Carmen Hockey, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 11, 2015
From Epidemic Meningitis Vaccines for Africa to the Meningitis Vaccine ProjectM Teresa Aguado, Luis Jodar, Dan Granoff, et al.
Open Forum Infectious Diseases|July 25, 2022
Rates of Medically Attended RSV Among US Adults: A Systematic Review and Meta-analysisJohn M McLaughlin, Farid Khan, Elizabeth Begier, et al.
Vaccine|December 1, 2019
Letter to the editorAdriano Arguedas, Bradford D Gessner, Scott Williams, et al.
Human Vaccines & Immunotherapeutics|September 8, 2023
Real-world impact and effectiveness of MenACWY-TTRodolfo Villena, Paula Kriz, Myint Tin Tin Htar, et al.
Expert Review of Vaccines|August 3, 2018
Response to Mungall et al. letter to the editor on Streptococcus pneumoniae serotype 19A: worldwide epidemiology. Expert review of vaccines 2017;16(10):1007-27Raul Isturiz, Heather L Sings, Betsy Hilton, et al.
The Journal of Infectious Diseases|April 23, 2019
The Persistence of Pneumococcal Conjugate Vaccine Types 3, 19A, and 19F in the UK Adult PopulationMary Slack, Andrew Vyse, Harish Madhava, et al.
Expert Review of Vaccines|April 26, 2022
Correlates of protection for meningococcal surface protein vaccines: current approaches for the determination of breadth of coverageJamie Findlow, Ray Borrow, David S Stephens, et al.
Scientific Reports|January 23, 2025
Tick-borne encephalitis vaccine uptake, effectiveness, and impact in Sweden from 2018 to 2022Andreas Palmborg, Frederick J Angulo, Pingping Zhang, et al.
Communications Medicine|May 3, 2025
Effectiveness of a single COVID-19 mRNA vaccine dose in individuals with prior SARS-CoV-2 infection: a systematic reviewHannah R Volkman, Jennifer L Nguyen, Mustapha M Mustapha, et al.
Pageof 16

Showing results (31-40 of 151) with videos related to

Sort By:
Pageof 16
Infectious Diseases and Therapy|December 23, 2025
How do Recent Population-Level RSVpreF Vaccine-Impact Results from the United Kingdom Relate to Previously Reported Vaccine Effectiveness Results?Negar Aliabadi, Qing Liu, Carmen Hockey, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 11, 2015
From Epidemic Meningitis Vaccines for Africa to the Meningitis Vaccine ProjectM Teresa Aguado, Luis Jodar, Dan Granoff, et al.
Open Forum Infectious Diseases|July 25, 2022
Rates of Medically Attended RSV Among US Adults: A Systematic Review and Meta-analysisJohn M McLaughlin, Farid Khan, Elizabeth Begier, et al.
Vaccine|December 1, 2019
Letter to the editorAdriano Arguedas, Bradford D Gessner, Scott Williams, et al.
Human Vaccines & Immunotherapeutics|September 8, 2023
Real-world impact and effectiveness of MenACWY-TTRodolfo Villena, Paula Kriz, Myint Tin Tin Htar, et al.
Expert Review of Vaccines|August 3, 2018
Response to Mungall et al. letter to the editor on Streptococcus pneumoniae serotype 19A: worldwide epidemiology. Expert review of vaccines 2017;16(10):1007-27Raul Isturiz, Heather L Sings, Betsy Hilton, et al.
The Journal of Infectious Diseases|April 23, 2019
The Persistence of Pneumococcal Conjugate Vaccine Types 3, 19A, and 19F in the UK Adult PopulationMary Slack, Andrew Vyse, Harish Madhava, et al.
Expert Review of Vaccines|April 26, 2022
Correlates of protection for meningococcal surface protein vaccines: current approaches for the determination of breadth of coverageJamie Findlow, Ray Borrow, David S Stephens, et al.
Scientific Reports|January 23, 2025
Tick-borne encephalitis vaccine uptake, effectiveness, and impact in Sweden from 2018 to 2022Andreas Palmborg, Frederick J Angulo, Pingping Zhang, et al.
Communications Medicine|May 3, 2025
Effectiveness of a single COVID-19 mRNA vaccine dose in individuals with prior SARS-CoV-2 infection: a systematic reviewHannah R Volkman, Jennifer L Nguyen, Mustapha M Mustapha, et al.
Pageof 16